Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$101.05 - $133.57 $2,324 - $3,072
-23 Reduced 1.02%
2,227 $232,000
Q1 2024

May 08, 2024

SELL
$127.73 - $147.2 $1,405 - $1,619
-11 Reduced 0.49%
2,250 $308,000
Q4 2023

Feb 07, 2024

BUY
$92.79 - $142.53 $12,619 - $19,384
136 Added 6.4%
2,261 $314,000
Q3 2023

Oct 19, 2023

BUY
$128.91 - $192.44 $59,556 - $88,907
462 Added 27.78%
2,125 $291,000
Q2 2023

Jul 17, 2023

BUY
$183.43 - $232.67 $47,875 - $60,726
261 Added 18.62%
1,663 $311,000
Q1 2023

May 04, 2023

BUY
$193.75 - $232.55 $6,006 - $7,209
31 Added 2.26%
1,402 $326,000
Q4 2022

Feb 01, 2023

SELL
$187.24 - $242.74 $36,886 - $47,819
-197 Reduced 12.56%
1,371 $277,000
Q3 2022

Oct 24, 2022

SELL
$177.23 - $227.44 $4,253 - $5,458
-24 Reduced 1.51%
1,568 $299,000
Q2 2022

Jul 26, 2022

BUY
$181.58 - $368.0 $74,084 - $150,144
408 Added 34.46%
1,592 $293,000
Q1 2022

May 05, 2022

BUY
$303.87 - $423.8 $23,397 - $32,632
77 Added 6.96%
1,184 $413,000
Q4 2021

Jan 26, 2022

BUY
$347.28 - $421.83 $12,849 - $15,607
37 Added 3.46%
1,107 $421,000
Q3 2021

Oct 21, 2021

SELL
$405.61 - $524.84 $180,090 - $233,028
-444 Reduced 29.33%
1,070 $434,000
Q2 2021

Jul 26, 2021

SELL
$372.84 - $481.5 $2,982 - $3,852
-8 Reduced 0.53%
1,514 $716,000
Q1 2021

May 04, 2021

SELL
$361.28 - $504.76 $21,676 - $30,285
-60 Reduced 3.79%
1,522 $584,000
Q4 2020

Jan 26, 2021

BUY
$292.7 - $370.96 $43,905 - $55,644
150 Added 10.47%
1,582 $585,000
Q3 2020

Oct 19, 2020

BUY
$268.51 - $400.74 $82,432 - $123,027
307 Added 27.29%
1,432 $442,000
Q2 2020

Aug 04, 2020

BUY
$256.46 - $373.01 $288,517 - $419,636
1,125 New
1,125 $416,000
Q1 2020

May 01, 2020

SELL
$209.2 - $335.53 $72,383 - $116,093
-346 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$288.29 - $335.49 $99,748 - $116,079
346 New
346 $114,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Great Diamond Partners, LLC Portfolio

Follow Great Diamond Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.